Post Reply
1101-1106 of 1106
It was previously listed on Australia Stock Exchange (ASX) and known as Cygenics Limited.
Renamed as Cordlife Group Limited (" Cordlife" or the " Company" ) has 2 core businesses: Cord blood banking and umbilical cord tissue banking. It now focuses on 3 countries, S'pore, Hong Kong and China.
It industry prospects -- It business model is somewhat like a " specialized" storage hub as larger of two private cord blood bank operators in Singapore in terms of market share.
• Currently stored in excess of 35,000 cord blood units in Singapore and Hong Kong
• Second largest private cord blood bank player in terms of market share in Hong Kong
A new interesting business model, question is...can the Co continue be able to sustain it profitability, just like in ASX??.
http://investing.businessweek.com/research/stocks/snapshot/snapshot.asp?ticker=CBB:AU
http://www.asx.com.au/asx/research/companyInfo.do?by=asxCode& asxCode=CBB
teeth53 ( Date: 22-Mar-2012 22:36) Posted:
|
Latest news...
A policy revision Facebook hoped would clarify its methods has sparked a privacy backlash. More
The IBM patent purchase will boost Facebook’s patent count over 800 in the US. By fighting fire with fire, it may be able to avoid a costly settlement or a plummeting post-IPO stock price. Instead it could come to a cross-licensing agreement with Yahoo or sue the old web portal in response if negotiations break down.
The bundle of patents from IBM could also help Facebook ward off other lawsuits. The company was targeted by 22 patent suits last year, and I’ve heard that Facebook paid to settle some of them. Meanwhile the sale will hardly dent IBM’s patent war chest, which grew by 6,180 last year alone. Patent sales are important business for the hardware company. IBM sold 1,000 to Google back in 2010.
Much of the tech industry railed against Yahoo for going on the offensive, and they’d probably prefer some sort of patent disarmament. Instead we’ve got a patent arms race and mutually assured destruction. Facebook likely shelled out big bucks for its new arsenal. Poorer startups may not have that option, and they could become Yahoo’s next targets.
teeth53 ( Date: 23-Mar-2012 22:06) Posted:
|
http://techcrunch.com/2012/03/22/facebook-buys-750-ibm-patents-to-defend-against-yahoo/
Facebook has just bought some troll repellant in the form of 750 patents for networking, software, and other technologies from IBM according to Bloomberg. If Yahoo relies any of those technologies, Facebook could use the patents to counteract Yahoo’s patent infringement lawsuit against it.
The purchase means Facebook may be in less danger for now, but it doesn’t stop Yahoo from trolling other companies with its vague social networking and advertising patents.
Facebook was in danger of having to either settle with Yahoo or license the old tech giant’s patents to avoid uncertainty heading into its own IPO. It could have tried to invalidate Yahoo’s patents in court, but that case could have spilled over its IPO date and scared away investors.
http://masnet.mas.gov.sg/opera/sdrprosp.nsf/36858ca0bf0879fb48256b4500285a82/9EACA03D87820501482579C80040246C/$File/51883376_1_3(a)%20Final%20Prospectus.PDF
Invitation in respect of 60,000,000 New Shares comprising:
(1) 2,000,000 Offer Shares at the Invitation Price (as defi ned herein) of S$0.495 for each Offer Share by way of public offer (the “Public Offer”) and
(2) 58,000,000 Placement Shares at the Invitation Price of S$0.495 for each Placement Share by way of placement (the “Placement”, together with the Public Offer, the “Invitation”),
payable in full on application.
Closing for the Public Offer -- Mar 27, 2012. (12.00 noon)
First day trading on the SGX-ST -- Mar 29, 2012. (9.00 a.m.)
teeth53 ( Date: 22-Mar-2012 22:29) Posted:
|
Cord for life...IPO On Offer at 0.495 cts.
http://masnet.mas.gov.sg/opera/sdrprosp.nsf/36858ca0bf0879fb48256b4500285a82/9EACA03D87820501482579C80040246C/$File/51883376_1_3(a)%20Final%20Prospectus.PDF